Chest CT findings may help predict outcomes of SBRT in stage I lung cancer
Written By : Dr. Kamal Kant Kohli
Published On 2022-04-16 03:30 GMT | Update On 2022-04-16 03:30 GMT
Advertisement
Leesburg: Imaging findings on chest CT conducted before a patient undergoes stereotactic body radiation therapy (SBRT) for stage I lung cancer may help predict treatment outcome. Noncancerous imaging markers on chest CT performed before stereotactic body radiation therapy (SBRT) improve survival prediction, compared with clinical features alone, finds a new study.
The study has been published in the American Journal of Roentgenology (AJR).
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.